NEW YORK – LifeOmic said today that it has partnered with the Susan G. Komen Tissue Bank to improve breast cancer research.
Under the agreement, the Komen Tissue Bank will use LifeOmic's Precision Health Cloud platform for genomic, clinical, and imaging data aggregation and analysis, as well as for healthcare-compliant surveys.
The Komen Tissue Bank, a resource established by researchers at the Indiana University Melvin and Bren Simon Cancer Center and the IU School of Medicine, stores normal breast tissue and matched serum, plasma, and DNA. The bank offers high-quality, annotated tissue samples to scientists worldwide, who can access the "virtual tissue bank" to query the medical history of donors, request tissue, and download data. The current system does not, however, support genomic data.
LifeOmic and the Komen Tissue Bank will work together to deploy the virtual tissue bank onto the PHC's secure, reliable, and scalable platform that will enable researchers to query an extended data model, including whole-genome sequencing data. Users will also be able to use PHC analytics tools to overlay data reported from participants' clinical history with all other data.
"Using LifeOmic's PHC will expand the Virtual Tissue Bank's capabilities to help fuel ongoing treatment and prevention discovery," Jill Henry, chief operating officer of the Komen Tissue Bank at the IU Simon Cancer Center, said in a statement.